<code id='9AAA1170D5'></code><style id='9AAA1170D5'></style>
    • <acronym id='9AAA1170D5'></acronym>
      <center id='9AAA1170D5'><center id='9AAA1170D5'><tfoot id='9AAA1170D5'></tfoot></center><abbr id='9AAA1170D5'><dir id='9AAA1170D5'><tfoot id='9AAA1170D5'></tfoot><noframes id='9AAA1170D5'>

    • <optgroup id='9AAA1170D5'><strike id='9AAA1170D5'><sup id='9AAA1170D5'></sup></strike><code id='9AAA1170D5'></code></optgroup>
        1. <b id='9AAA1170D5'><label id='9AAA1170D5'><select id='9AAA1170D5'><dt id='9AAA1170D5'><span id='9AAA1170D5'></span></dt></select></label></b><u id='9AAA1170D5'></u>
          <i id='9AAA1170D5'><strike id='9AAA1170D5'><tt id='9AAA1170D5'><pre id='9AAA1170D5'></pre></tt></strike></i>

          explore

          explore

          author:fashion    Page View:199
          The headquarter of US biopharmaceutical company Vertex Pharmaceuticals with its logo sign— coverage from STAT
          JOSEPH PREZIOSO/AFP via Getty Images

          LONDON — The U.K.’s cost-effectiveness watchdog said Thursday it is not yet recommending Vertex’s CRISPR-based therapy for sickle cell disease, saying in draft guidance it has questions about the medicine’s lasting benefits for patients.

          U.K. regulators approved the therapy, known as Casgevy or exa-cel, last year, granting it the world’s first authorization for any CRISPR-based medicine. But observers have been watching to see how the U.K.’s National Institute for Health and Care Excellence, as well as similar agencies in European countries, would view the pricey, one-time therapy. NICE needs to recommend the therapy for it to be offered in the National Health Service.

          advertisement

          In the U.S., Casgevy has a list price of $2.2 million. It was developed by Vertex in partnership with CRISPR Therapeutics.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          The Supreme Court will review a ruling striking down a domestic violence federal gun ban
          The Supreme Court will review a ruling striking down a domestic violence federal gun ban

          WASHINGTON--TheSupremeCourtwillreviewarulingstrikingdownadomesticviolencefederalgunban.

          read more
          A look at other Americans who have crossed into North Korea over the years
          A look at other Americans who have crossed into North Korea over the years

          FILE-MatthewMiller,aU.S.citizen,sitsonthedockattheSupremeCourtduringhistrialinPyongyang,NorthKoreaon

          read more
          Tori Bowie and the unacceptable rates of Black maternal death
          Tori Bowie and the unacceptable rates of Black maternal death

          AlastairGrant/APThehorrorstoriesofBlackwomendyingorcomingclosetodeathinchildbirthneverseemtostopcomi

          read more

          More hospitals are billing patients as online messages surge

          AdobeHealthsystemsdrowninginmessagesfrompatientsaregraspingfornewwaystomanagethedeluge—includingchar